Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $29.57 in the prior trading day, Surgery Partners Inc (NASDAQ: SGRY) closed at $25.50, down -13.75%. In other words, the price has decreased by -$13.75 from its previous closing price. On the day, 2.34 million shares were traded. SGRY stock price reached its highest trading level at $30.11 during the session, while it also had its lowest trading level at $25.381.
Ratios:
Our goal is to gain a better understanding of SGRY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.84. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 1.86 whereas as Long-Term Debt/Eq ratio is at 1.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 14, 2024, initiated with a Buy rating and assigned the stock a target price of $38.
On June 28, 2024, Macquarie started tracking the stock assigning a Outperform rating and target price of $31.Macquarie initiated its Outperform rating on June 28, 2024, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 05 ’24 when Bradley Owens bought 9,241 shares for $30.69 per share.
Bane Harrison R. sold 6,325 shares of SGRY for $196,742 on Sep 04 ’24. The National Group President now owns 48,236 shares after completing the transaction at $31.11 per share. On Sep 04 ’24, another insider, Harrison Bane, who serves as the Officer of the company, bought 6,325 shares for $31.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 3759054080 and an Enterprise Value of 8592843776. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.09 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 2.974 whereas that against EBITDA is 14.928.
Stock Price History:
Over the past 52 weeks, SGRY has reached a high of $36.92, while it has fallen to a 52-week low of $22.25. The 50-Day Moving Average of the stock is -17.42%, while the 200-Day Moving Average is calculated to be -11.37%.
Shares Statistics:
The stock has traded on average 816.55K shares per day over the past 3-months and 953540 shares per day over the last 10 days, according to various share statistics. A total of 126.59M shares are outstanding, with a floating share count of 71.06M. Insiders hold about 44.10% of the company’s shares, while institutions hold 70.35% stake in the company. Shares short for SGRY as of 1728950400 were 10118737 with a Short Ratio of 12.44, compared to 1726185600 on 9984935. Therefore, it implies a Short% of Shares Outstanding of 10118737 and a Short% of Float of 17.52.
